NUI Galway

Faculty Member, Anatomy & Psychiatry

Lecturer & Research Scientist

College of Medicine, Nursing and Health Sciences

About

POSTGRADUATE OPPORTUNITIES

The Hardiman Research Scholars Scheme is now closed for 2011, look out for 2012 information:
http://www.nuigalway.ie/about-us/news-and-events/hardiman-scholarships/index.html
Closing date last year was 19th June, 2011.

College of Medicine, Nursing and Health Sciences Fellowship Scheme information here: http://www.nuigalway.ie/colleges/mnhs/fellowships.html
Closing date for the scheme last year was 24th of June 2011.

MD part-time over 2 years, get in touch (e-mail below).

NIH Graduate Partnership Program . Welcome Trust/NIH initiative. Closed for 2011 -  Deadlines passed: Molecular Medicine Ireland - structure PhD positions, IRCSET PhD Scholarships, IRCSET postdoctoral Scheme, NUI Galway College Science Fellowships - Masters or PhD by research.


MASTERS PROGRAMME

'Translational Neuroscience: Psychiatry and Neurology' is under development and I will update here and via twitter when the first enrollment year will be available.


UNDERGRADUATE OPPORTUNITIES

options for this summer - HRB Summer Student Scholarships, Welcome Trust Biomedical Vacation Scholarships. SFI UREKA has been discontinued. If you are interested in gaining experience in our lab this summer please get in touch - Clinical Neuroimaging Lab, NUI Galway dara.cannon@nuigalway.ie



PROFILE

Lecturer and Research Scientist, Dept Anatomy, School of Medicine, National University of Ireland Galway.

Co-Director, Clinical Neuroimaging Laboratory, NUI Galway
http://www.nuigalway.ie/psychiatry/research/neuroimaging_lab/

Organizer, Irish Diffusion Imaging Group (IDIG)
http://www.idig.synthasite.com

Associate Editor, Translational Neuroscience
http://www.versita.com/science/medicine/tn/

Follow me on Twitter
http://twitter.com/#!/DaraCannon


LATEST FINDINGS AND COMMUNICATIONS

Recent: Genetic variation in cholinergic muscarinic-2 receptor gene modulates M(2) receptor binding in vivo and accounts for reduced binding in bipolar disorder. Invited presentation at the WFSBP (www.wfsbp-congress.org) May 2011 Prague.

Radio Interview: July 22, 2010
http://sciencespin.podomatic.com/

Galway Neuroscience Research Day Dec 2nd, 2012 http://galwayneuroscience.yolasite.com/

Related News Article Mention: http://www.galwayindependent.com/local-news/local-news/nui-galway-researchers-win-awards/


Most Recent Awards:

The World Federation of Societies of Biological Psycahitry (WFSBP) Young Investigator Award. Prague, May 2011

The Rafaelson Young Investigator Award, Collegium Internationale Neuropsychopharmacology (CINP) June 2010

The Rising Star Award, European Psychiatric Association (EPA) Neuroimaging Section 2009


SELECT PUBLICATIONS

You can request a copy of any paper by e-mailing me dara.cannon@nuigalway.ie

My ResearchID profile:
http://www.researcherid.com/rid/C-1323-2009

Recent Advances in Psychoneuroimmunology: Inflammation in Psychiatric Disorders. Monojit Debnath, Karen M. Doyle, Camilla Langan, Colm McDonald, Brian Leonard, Dara M. Cannon. Translational Neuroscience 2(2), 2011, 121-137.

A non-synonymous polymorphism in galactose mutarotase (GALM) is associated with serotonin transporter binding potential in the human thalamus: results of a genome-wide association study. X Liu, DM Cannon, N Akula, PR Moya, GM Knudsen, TE Arentzen, J Steele, G Laje, WC Drevets and FJ McMahon. Molecular Psychiatry (2011), 1–2. Letter to the Editor.

Habenula Volume in Bipolar Disorder and Major Depressive Disorder: A High-Resolution Magnetic Resonance Imaging Study. Savitz JB, Nugent AC, Bogers W, Roiser JP, Bain EE, Neumeister A, Zarate CA Jr, Manji HK, Cannon DM, Marrett S, Henn F, Charney DS, Drevets WC. Biol Psychiatry. 2010 Nov 20. PMID: 21094939

Prefrontal cortical abnormalities in currently depressed versus currently remitted patients with major depressive disorder. Salvadore G, Nugent AC, Lemaitre H, Luckenbaugh DA, Tinsley R, Cannon DM, Neumeister A, Zarate CA, Drevets WC. Neuroimage (In Press).

Genetic variation in cholinergic muscarinic-2 receptor gene modulates M(2) receptor binding in vivo and accounts for reduced binding in bipolar disorder. Cannon DM, Klaver JK, Gandhi SK, Solorio G, Peck SA, Erickson K, N Akula JS, Eckelman WC, Furey ML, Sahakian BJ, McMahon FJ, Drevets WC. Mol Psychiatry. 2010 Mar 30. [Epub ahead of print] PMID: 20351719

Genetic variation in HTR2A influences serotonin transporter binding potential as measured using PET and [11C]DASB. Laje G*, Cannon DM*, Allen AS, Klaver JM, Peck SA, Liu X, Manji HK, Drevets WC, McMahon FJ. Int J Neuropsychopharmacol. 2010 Jul;13(6):715-24. Epub 2010 Jan 5. PMID: 20047709 *These authors contributed equally to this work.

Amygdala volume in depressed patients with bipolar disorder assessed using high resolution 3T MRI: the impact of medication. Savitz J, Nugent AC, Bogers W, Liu A, Sills R, Luckenbaugh DA, Bain EE, Price JL, Zarate C, Manji HK, Cannon DM, Marrett S, Charney DS, Drevets WC. Neuroimage. 2010 Feb 15;49(4):2966-76. Epub 2009 Nov 17. PMID: 19931399

Reduced occipital and prefrontal brain volumes in dysbindin-associated schizophrenia.Donohoe G, Frodl T, Morris D, Spoletini I, Cannon DM, Cherubini A, Caltagirone C, Bossù P, McDonald C, Gill M, Corvin AP, Spalletta G. Neuropsychopharmacology. 2010 Jan;35(2):368-73. Epub .
PMID: 19794403

Dopamine Type-1 Receptor Binding in Major Depressive Disorder Assessed Using Positron Emission Tomography and [(11)C]NNC-112. Cannon DM, Klaver JM, Peck SA, Rallis-Voak D, Erickson K, Drevets WC. Neuropsychopharmacology. 2008 Oct 22. [Epub ahead of print] PMID: 18946469

Bcl-2 polymorphism influences gray matter volume in the ventral striatum in healthy humans. Salvadore G, Nugent AC, Chen G, Akula N, Yuan P, Cannon DM, Zarate CA Jr, McMahon FJ, Manji HK, Drevets WC. Biol Psychiatry. 2009 Oct 15;66(8):804-7. Epub 2009 Jul 9. Erratum in: Biol Psychiatry. 2009 Oct 15;66(8):808.
PMID: 19589501

Distinct profiles of neurocognitive function in unmedicated unipolar depression and bipolar II depression.Taylor Tavares JV, Clark L, Cannon DM, Erickson K, Drevets WC, Sahakian BJ. Biol Psychiatry. 2007 Oct 15;62(8):917-24. Epub 2007 Sep 7. PMID: 17825802

Elevated serotonin transporter binding in major depressive disorder assessed using positron emission tomography and [11C]DASB; comparison with bipolar disorder. Cannon DM, Ichise M, Rollis D, Klaver JM, Gandhi SK, Charney DS, Manji HK, Drevets WC. Biol Psychiatry. 2007 Oct 15;62(8):870-7. Epub 2007 Aug 2. PMID: 17678634

Serotonin transporter binding in bipolar disorder assessed using [11C]DASB and positron emission tomography. Cannon DM, Ichise M, Fromm SJ, Nugent AC, Rollis D, Gandhi SK, Klaver JM, Charney DS, Manji HK, Drevets WC. Biol Psychiatry. 2006 Aug 1;60(3):207-17. PMID: 16875929

Reduced muscarinic type 2 receptor binding in subjects with bipolar disorder. Cannon DM, Carson RE, Nugent AC, Eckelman WC, Kiesewetter DO, Williams J, Rollis D, Drevets M, Gandhi S, Solorio G, Drevets WC. Arch Gen Psychiatry. 2006 Jul;63(7):741-7. Erratum in: Arch Gen Psychiatry. 2006 Nov;63(11):1208. PMID: 16818863

Hot and cold cognition in unmedicated depressed subjects with bipolar disorder. Roiser JP, Cannon DM, Gandhi SK, Tavares JT, Erickson K, Wood S, Klaver JM, Clark L, Zarate CA Jr, Sahakian BJ, Drevets WC. Bipolar Disord. 2009 Mar;11(2):178-89.PMID: 19267700

A comparison of cognitive functioning in medicated and unmedicated subjects with bipolar depression. Holmes MK, Erickson K, Luckenbaugh DA, Drevets WC, Bain EE, Cannon DM, Snow J, Sahakian BJ, Manji HK, Zarate CA Jr.
Bipolar Disord. 2008 Nov;10(7):806-15. PMID: 19032712

Mood-congruent bias in affective go/no-go performance of unmedicated patients with major depressive disorder. Erickson K, Drevets WC, Clark L, Cannon DM, Bain EE, Zarate CA Jr, Charney DS, Sahakian BJ. Am J Psychiatry. 2005 Nov;162(11):2171-3. PMID: 16263859

Cortical abnormalities in bipolar disorder investigated with MRI and voxel-based morphometry. Nugent AC, Milham MP, Bain EE, Mah L, Cannon DM, Marrett S, Zarate CA, Pine DS, Price JL, Drevets WC. Neuroimage. 2006 Apr 1;30(2):485-97. Epub 2005 Oct 26. PMID: 16256376

In vitro neuronal and vascular responses to 5-HT in rats chronically exposed to MDMA. Cannon DM, Keenan AK, Guiry PJ, Buon C, Baird AW, McBean GJ. Br J Pharmacol. 2001 Dec;134(7):1455-60. PMID: 11724751

In vitro neuronal and vascular responses to 5-hydroxytryptamine: modulation by 4-methylthioamphetamine, 4-methylthiomethamphetamine and 3,4-methylenedioxymethamphetamine. Murphy J, Flynn JJ, Cannon DM, Guiry PJ, McCormack P, Baird AW, McBean GJ, Keenan AK. Eur J Pharmacol. 2002 May 24;444(1-2):61-7. PMID: 12191583